Sort
40,608 grants matching “prostate cancer”
Calcium Channel CaT 1 in Prostate Cancer Prevention
$300,001Brigham And Women'S Hospital · R01 · FY2005 · CA
Calcium Channel CaT 1 in Prostate Cancer Prevention
$300,001Brigham And Women'S Hospital · R01 · FY2004 · CA
Calcium Channel CaT 1 in Prostate Cancer Prevention
$300,001Brigham And Women'S Hospital · R01 · FY2003 · CA
RADIATION THERAPY ONCOLOGY GROUP
$300,000Walter John Curran · American College Of Radiology · U10 · FY2007 · CA
Androgen Receptor-JunD Complex Inhibitors to Prevent Prostate Cancer Progression
$300,000Hirak S. Basu · Colby Pharmaceutical Company · R43 · FY2012 · CA
Development of a PSMA-Targeted Small-Molecule Drug Conjugate for Prostate Cancer
$300,000Beatrice Langton-Webster · Cancer Targeted Technology, Llc · R43 · FY2018 · CA
Emory-GA Tech Nanotechnology Center for Personalized an*
$300,000Shuming Nie · Emory University · U54 · FY2009 · CA
Targeting galectin-3 to overcome drug resistance in metastatic prostate cancer therapy
$300,000Hafiz Ahmed · Glycomantra, Inc. · R43 · FY2018 · CA
GASTROINTESTINAL MICROBIOTA AND IMMUNOTHERAPY IN ADVANCED PROSTATE CANCER
$300,000The Johns Hopkins University · · FY2018 · Department of the Army
Development of a Machine Learning Model for Prostate Cancer Treatment Planning
$300,000Roberto Nicolalde · Nicolalde R And D, Llc · N43 · FY2019 · CA
TOPIC 389 - INTELLIGENT SOFTWARE FOR RADIATION THERAPY PLANNING
$300,000Jonathan Edelen · Radiasoft, Llc · N43 · FY2019 · CA
NEW AWARD - THE ROLE OF MITOCHONDRIAL METABOLISM IN PROSTATE CANCER PROGRESSION AND SUSCEPTIBILITY TO BIPOLAR ANDROGEN THERAPY...EFFECTIVE 7/1/2020, SIGNED 1/14/2020, DISTRIBUTED 1/16/2020, FAADC 1/16/2020
$300,000The Johns Hopkins University · · FY2020 · Department of the Army
Pre-clinical validation and verification of a biology-guided radiation therapy system
$300,000Samuel Mazin · Reflexion Medical, Inc. · R44 · FY2018 · CA
Development of an Innovative PSMA-targeted Radionuclide Therapy for Prostate Cancer
$300,000Beatrice Langton-Webster · Cancer Targeted Technology, Llc · N43 · FY2015 · CA
Prospective metabolomics investigation of gastric cancer risk in African Americans and European Whites with a low socioeconomic status
$300,000Xiang Shu · Sloan-Kettering Inst Can Research · R56 · FY2023 · CA
The utility of a mining byproduct, thorium, and a novel radium separation technique to provide full value chain radioisotope supply for Ra224, Ac225, and Pb212 oncology drugs
$300,000Saleem Drera · Radtran Llc · R43 · FY2021 · CA
Production & Crystallization of Membrane Protein for 3D Structure
$300,000Lawrence J Delucas · University Of Alabama At Birmingham · R01 · FY2010 · GM
CANCER EPIDEMIOLOGY IN ADVENTISTS--A LOW RISK GROUP
$300,000Gary E. Fraser · Loma Linda University · R01 · FY2008 · CA
The re-activatable Yb-169 radiation source: a therapeutic medical device to reduce the risk of brachytherapy and increase adoption
$300,000Ryan Thomas Flynn · Pxalpha, Llc · R41 · FY2022 · CA
DNA Quadruplex Control of hTERT Transcription: A New Therapy for Taxotere Resistant Prostate Cancer
$300,000Laurence H Hurley · Reglagene, Llc · R41 · FY2018 · CA
Development and Validation of a Collaborative Web-Based Quantitative Imaging and Dosimetry System for Radiopharmaceutical Therapy
$300,000Michael Ghaly · Radiopharmaceutical Imaging And Dosimetry, Llc · R43 · FY2017 · CA
Telomere length and chromosomal instability across various tissue types
$300,000Brandon Lee Pierce · University Of Chicago · U01 · FY2015 · HG
Therapeutic Vaccine for Asthma
$300,000Peter Blackburn · Mercia Pharma, Inc. · R41 · FY2008 · AI
EAGER: Integrating Multiple Biomarkers in Nano-Sensor Arrays for Enhanced Detection of Prostate Cancer
$300,000Frances R Williams · Tennessee State University · · FY2016 · EDU
Robust Predictor of Breast Cancer Risk
$300,000Harry Ostrer · Morgan And Mendel Genomics, Inc. · R41 · FY2017 · CA